Suppr超能文献

K3.1钾通道激活和LRRC8A阴离子通道抑制对THP-1分化的巨噬细胞中CCL2转录的抑制作用

Transcriptional Repression of CCL2 by K3.1 K Channel Activation and LRRC8A Anion Channel Inhibition in THP-1-Differentiated M Macrophages.

作者信息

Matsui Miki, Kajikuri Junko, Kito Hiroaki, Yamaguchi Yohei, Ohya Susumu

机构信息

Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.

出版信息

Int J Mol Sci. 2025 Aug 6;26(15):7624. doi: 10.3390/ijms26157624.

Abstract

We investigated the role of the intermediate-conductance, Ca-activated K channel K3.1 and volume-regulatory anion channel LRRC8A in regulating C-C motif chemokine ligand 2 (CCL2) expression in THP-1-differentiated M macrophages (M-MACs), which serve as a useful model for studying tumor-associated macrophages (TAMs). CCL2 is a potent chemoattractant involved in the recruitment of immunosuppressive cells and its expression is regulated through intracellular signaling pathways such as ERK, JNK, and Nrf2 in various types of cells including macrophages. The transcriptional expression of CCL2 was suppressed in M-MACs following treatment with a K3.1 activator or an LRRC8A inhibitor via distinct signaling pathways: ERK-CREB2 and JNK-c-Jun pathways for K3.1, and the NOX2-Nrf2-CEBPB pathway for LRRC8A. Under in vitro conditions mimicking the elevated extracellular K concentration ([K]) characteristic of the tumor microenvironment (TME), CCL2 expression was markedly upregulated, and this increase was reversed by treatment with them in M-MACs. Additionally, the WNK1-AMPK pathway was, at least in part, involved in the high [K]-induced upregulation of CCL2. Collectively, modulating K3.1 and LRRC8A activities offers a promising strategy to suppress CCL2 secretion in TAMs, potentially limiting the CCL2-induced infiltration of immunosuppressive cells (TAMs, Ts, and MDSCs) in the TME.

摘要

我们研究了中电导钙激活钾通道K3.1和容积调节性阴离子通道LRRC8A在调节THP-1分化的M巨噬细胞(M-MACs)中C-C基序趋化因子配体2(CCL2)表达中的作用,M-MACs是研究肿瘤相关巨噬细胞(TAMs)的有用模型。CCL2是一种强效趋化因子,参与免疫抑制细胞的募集,其表达在包括巨噬细胞在内的各种细胞中通过细胞内信号通路如ERK、JNK和Nrf2进行调节。在用K3.1激活剂或LRRC8A抑制剂处理后,M-MACs中CCL2的转录表达通过不同的信号通路被抑制:K3.1通过ERK-CREB2和JNK-c-Jun通路,LRRC8A通过NOX2-Nrf2-CEBPB通路。在模拟肿瘤微环境(TME)特征性细胞外钾浓度([K])升高的体外条件下,CCL2表达明显上调,而在M-MACs中用它们处理可逆转这种增加。此外,WNK1-AMPK通路至少部分参与了高[K]诱导的CCL2上调。总体而言,调节K3.1和LRRC8A的活性为抑制TAMs中CCL2分泌提供了一种有前景的策略,可能限制TME中CCL2诱导的免疫抑制细胞(TAMs、Ts和MDSCs)的浸润。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee3c/12347553/203689f7f662/ijms-26-07624-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验